I-EZER Flu&COVID-19 Antigen Combo Rapid Test
Isingeniso
I-influenza virus ingeyomndeni wakwaOrthomyxoviridae, kanye namagciwane e-RNA anomucu owodwa ahlukahlukene.Kukhona igciwane lomkhuhlane A no-B yilona gciwane elidala izifo ezinzima kubantu nasezinhlotsheni eziningi zezilwane.Ngokusekelwe ophenyweni lwamanje lwe-epidemiological, isikhathi sokufukamela siyizinsuku ezi-1 kuya kwezi-4.Izimpawu eziyinhloko zihlanganisa imfiva enzima, ukuqaqamba okujwayelekile kanye nezimpawu zokuphefumula.Womabili amagciwane oHlobo A no-B angajikeleza ngesikhathi esisodwa, kodwa ngokuvamile uhlobo olulodwa lunamandla phakathi nenkathi ethile.
I-COVID-19 yisifo esithathelwanayo sokuphefumula esinamandla.Ngokuvamile abantu bayathinteka.Njengamanje, iziguli ezingenwe yi-coronavirus yenoveli ziwumthombo oyinhloko wokutheleleka;abantu abane-asymptomatic abangenwe yileli gciwane bangaba umthombo othathelwanayo.Ngokusekelwe ophenyweni lwamanje lwe-epidemiological, isikhathi sokufukamela siyizinsuku ezi-1 kuya kweziyi-14, izikhathi eziningi izinsuku ezi-3 kuya kweziyi-7.Izimpawu eziyinhloko zihlanganisa umkhuhlane, ukukhathala nokukhwehlela okomile.Ukucinana kwamakhala, ikhala eligijimayo, umphimbo obuhlungu, i-myalgia kanye nesifo sohudo kutholakala ezimweni ezimbalwa.
Izimpawu zomtholampilo nezimpawu zokutheleleka ngegciwane lokuphefumula ngenxa ye-SARS-CoV-2 kanye nomkhuhlane zingafana.I-SARS-CoV-2, i-influenza A kanye nama-antigens wegciwane lomkhuhlane B ngokuvamile atholakala ezibonelweni eziphezulu zokuphefumula ngesikhathi sesigaba esibi kakhulu sokutheleleka.
I-EZERTMI-Flu&COVID-19 Antigen Combo Rapid Test ihlanganisa ukuhlolwa okusheshayo kwe-influenza antigen kanye nokuhlola okusheshayo kwe-COVID-19 antigen, isivivinyo se-immunochromatographic sokutholwa kwekhwalithi ye-Novel Coronavirus ka-2019, umkhuhlane A kanye nama-antigen B.I-EZERTMI-Flu&COVID-19 Antigen Combo Rapid Test inezinhlamvu ezine phezu kwemicu ebonisa umugqa wokuhlola (S)﹑ (A)﹑ (B) kanye nolayini wokulawula (C).
Ukutholwa
EZERTMI-Flu&COVID-19 Antigen Combo Rapid Test ihloselwe ukutholwa kwekhwalithi kanye kanye nokuhlukaniswa kwama-nucleocapsid protein antigens asuka kwa-SARS-CoV-2, umkhuhlane A kanye nomkhuhlane B emifanekisweni eqondile yamakhala.
Isifanekiso
Ikhala
Umkhawulo Wokutholwa (LoD)
Umkhuhlane&COVID-19 :140 TCID50/mL
Umkhawulo omncane wokutholwa we-Flu A we-EZERTMI-Flu&COVID-19 Antigen Combo Rapid Test yasungulwa ngokusekelwe enanini le-8 lomkhuhlane A.
| I-Influenza Viral Strain | I-LoD ebaliwe |
| A/New Caledonia/20/1999_H1N1 | 8.50x103 |
| A/California/04/2009_H1N1 | 2.11x103 |
| A/PR/8/34_H1N1 | 2.93x103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 | 4.94x102 |
| A/Guizhou/54/89_H3N2 | 3.95x102 |
| A/Human/Hubei/3/2005_H3N2 | 2.93x104 |
| I-A/Bar-headed Goose/QH/BTY2/2015_H5N1 | 1.98x105 |
| A/Anhui/1/2013_H7N9 | 7.90x105 |
Ubuncane bomkhawulo wokutholwa komkhuhlane we-Flu B we-EZERTMI-Flu&COVID-19 Antigen Combo Rapid Test yasungulwa ngokusekelwe enanini le-2 lomkhuhlane B.
| I-Influenza Viral Strain | I-LoD ebaliwe |
| B/Victoria | 4.25x103 |
| B/Yamagata | 1.58x102 |
Ukunemba
|
| Umkhuhlane A | Umkhuhlane B | i-COVID-19 |
| Ukuzwela Okuhlobene | 86.8% | 91.7% | 96.6% |
| Ukucaciswa Okuhlobene | 94.0% | 97.5% | 100% |
| Ukunemba | 92.2% | 96.1% | 98.9% |
Isikhathi semiphumela
Funda imiphumela ngemizuzu eyi-15 futhi ungabi ngaphezu kwemizuzu engama-30.
Izimo zokugcina ikhithi
2~30°C
Okuqukethwe
| Incazelo | Qty |
| Hlola amadivayisi | 20 |
| Ama-swabs afakwe inzalo | 20 |
| Amashubhu okukhipha | 20 |
| Imilomo | 20 |
| I-Tube stand | 1 |
| Faka iphakheji | 1 |
Uku-oda Ulwazi
| Umkhiqizo | Ikati.No. | Okuqukethwe |
| EZERTMI-Flu&COVID-19 Antigen Combo | P213110 | 20 Ukuhlolwa |
